Description
An inhibitor of IRAK4 (IC50 = 0.2 nM in a cell-free assay); inhibits 100% of IRAK4 activity and is selective for IRAK4 over 273 kinases in a panel at 200 nM, but does inhibit IRAK1, MNK2, LRRK2, CLK4, and CLKɣ1 activity by greater than 70%; reduces levels of TNF-α and IL-6 in R848-stimulated isolated human whole blood and peripheral blood mononuclear cells (PBMCs), respectively (IC50 = ~2 nM for both); decreases LPS-induced increases in rat serum levels of TNF-α when administered at 1, 3, and 30 mg/kg.
Formal name: 1-[[(2S,3S,4S)-3-ethyl-4-fluoro-5-oxo-2-pyrrolidinyl]methoxy]-7-methoxy-6-isoquinolinecarboxamide
Synonyms:
Molecular weight: 361.4
CAS: 1817626-54-2
Purity: ≥98%
Formulation: A solid